Please select a HGH news story from the list below:
June 1, 2002 -- Genentech, Inc. (NYSE:DNA), South San Francisco, has announced that the Nutropin AQ Pen(TM) has received clearance from the FDA. The Nutropin AQ...
June 8, 2001 -- Business Editors SOUTH SAN FRANCISCO, Calif. & MONHEIM, Germany--(BUSINESS WIRE)-- June 7, 2001 Schwarz Pharma AG and Genentech, Inc. announced...
January 8, 2001 -- Business Editors NOTE: The following news release replaces and corrects the previous Genentech news release, which ran earlier Monday on...
June 29, 2000 -- M2 PRESSWIRE-29 June 2000-GENENTECH: Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available (C)1994-2000 M2...
June 28, 2000 -- Business Editors and Health/Medical Writers SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass.--(BW HealthWire)--June 28, 2000--Genentech, Inc....
June 1, 2000 -- Nutropin Depot (somatropin [rDNA origin] for injection), the first long-acting dosage form of recombinant growth hormone, is indicated for treating...
December 24, 1999 -- M2 PRESSWIRE-24 December 1999-US FDA: FDA approves Nutropin Depot, first long-acting dosage form of recombinant growth hormone for growth hormone...
December 3, 1999 -- M2 PRESSWIRE-3 December 1999-GENENTECH: FDA approves efficacy results for spine bone mineral density in childhood-onset growth hormone deficient...
February 1, 1999 -- M2 PRESSWIRE-1 February 1999-GENENTECH: Schwarz Pharma AG and Genentech enter into a collaboration for two growth hormone products (C)1994-99 M2...
cambridge monheim south san francisco
Our goal is to spread human growth hormone information in the form of general information and useful HGH articles from a wide variety of print publications.
If we've proved to be a useful resource why not now?
designed: expert answers